Artwork

Content provided by Garrett Tiedemann and ALS Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Garrett Tiedemann and ALS Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

FDA Advisory Committee to Consider Tofersen…

27:23
 
Share
 

Manage episode 357471954 series 2814839
Content provided by Garrett Tiedemann and ALS Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Garrett Tiedemann and ALS Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This week Jeremy talks to Dr. Neil Thakur about The ALS Association’s comments to the FDA urging them to approve tofersen, a gene therapy targeting SOD1 mutations. He then digs into the tofersen clinical trials with lead investigator Dr. Timothy Miller.

For more information on genetic testing and counseling go to https://www.als.org/understanding-als/who-gets-als/genetic-testing

This episode is brought to you by The ALS Association in partnership with CitizenRacecar.

  continue reading

202 episodes

Artwork
iconShare
 
Manage episode 357471954 series 2814839
Content provided by Garrett Tiedemann and ALS Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Garrett Tiedemann and ALS Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This week Jeremy talks to Dr. Neil Thakur about The ALS Association’s comments to the FDA urging them to approve tofersen, a gene therapy targeting SOD1 mutations. He then digs into the tofersen clinical trials with lead investigator Dr. Timothy Miller.

For more information on genetic testing and counseling go to https://www.als.org/understanding-als/who-gets-als/genetic-testing

This episode is brought to you by The ALS Association in partnership with CitizenRacecar.

  continue reading

202 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide